Familien-SCOUT: Comprehensive Support for Families With a Parent Suffering From Cancer

Families With Minor Children and One Parent Suffering From Cancer Clinical Trial

— F-SCOUT  

Official title:

Familien-SCOUT: Comprehensive Support for Families With a Parent Suffering From Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04186923
• Other study ID #: 18-033
• Status: Completed
• Phase: N/A
• Start date: October 1, 2019
• Est. completion date: June 1, 2022

Study information

• Verified date: October 2022
• Source: RWTH Aachen University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

When a parent with minor children falls ill with cancer, it is extremely stressful for all of the family members, including the partner and children. Familiar everyday routines are often disrupted even at an early stage, and for a prolonged period. Financial difficulties, the threat represented by the uncertain course of the disease, and worries about the children's future have a cumulative effect. The affected families are thereby pushed to their limits organizationally and emotionally. The burden involved tends to be underestimated, and secondary psychological conditions often develop among all the family members. They often do not have adequate access to support.

The aim of this project is to establish a care management system that provides support for families with underage children in which one parent is seriously ill. In order to reduce the burden on families, "family SCOUTS" are to be used who can provide advice and information at an early stage. They are intended to encourage families to discuss things openly, and they should also facilitate access to all the support services available.

The project will evaluate whether the use of family SCOUTS reduces the burden on the family in comparison with families who do not have a family SCOUT. For this purpose, investigations will be carried out before and after the family SCOUTS are deployed. Standardized questionnaires, interviews, and routine data from the participating health-insurance companies will provide the basic data.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 472
• Est. completion date: June 1, 2022
• Est. primary completion date: September 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 8 Years and older

Eligibility

Inclusion Criteria:

• Confirmed ICD diagnosis of cancer in one parent

• Custody of at least one underage child

• Adequate knowledge of German

• Availability of informed consent to participate in the study from the patient and/or healthy parent and linkage to questionnaire data and routine data

Exclusion Criteria:

• Withdrawal of consent by the ill or healthy parent

• Relevant cognitive limitation, advanced dementia

• Individuals who are in relationships of dependence or employment to the project managers or their representatives

Related Conditions & MeSH terms

• Families With Minor Children and One Parent Suffering From Cancer
• Stress, Psychological

Intervention

Other:
• F-SPOKE
This project includes communicative, emotional, and also organizational support with outreach across different sectors and phases (F-SPOKE - family-centered, cross-sector and cross-phase organizational, communicative, and emotional support).

Locations

Country	Name	City	State
Germany	Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University	Aachen
Germany	Department of Psychosomatic Medicine and Psychotherapy, University Hospital Bonn	Bonn
Germany	Clinical Institute of Psychosomatic Medicine and Psychotherapy, Heinrich-Heine-University Duesseldorf	Duesseldorf

Sponsors (1)

Lead Sponsor	Collaborator
RWTH Aachen University

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hospital Anxiety and Depression Scale (HADS	HADS is used to record anxiety and depression in patients with physical diseases or psychogenic physical symptoms.Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression. The HADS uses a scale and therefore the data returned from the HADS is ordinal.	Change from Baseline HADS at 9 months
Secondary	Distress Thermometer (DT)	DT is a screening instrument developed by the National Comprehensive Cancer Network (NCCN) for registering psychosocial stress in oncological patients. It consists of a scale from 0 to 10 and a list of problems, providing a scheme for referral to the relevant professional services.	baseline & 9 month
Secondary	Parenting Concerns Questionnaire (PCQ)	PCQ is used to record concerns among parents who have developed cancer. It includes 15 items with a 5-level response scale.	baseline and 9 month
Secondary	HLS-EU-Q16	HLS-EU-Q16 measures health competenceliteracy, using 16 items and a four-level response scale.	3 month
Secondary	PA-F-P-KF	The short form of the Fear of Progression Anxiety Questionnaire for Partners (PA-F-P-KF) records anxieties regarding progression fear of progression in healthy partners of individuals with chronic disease. The scale includes 12 items, each with a 5-level scale of response categories.	baseline & 9 month
Secondary	CaPIN	The Cancer Patient Information Needs (CaPIN) scale measures information needs on various topics among cancer patients. The scale consists of 22 items with binary-coded response categories (yes/no).	3 & 9 Month
Secondary	MOS-SS	This instrument is a subscale of the validated "Medical Outcomes Study Social Support (MOS-SS) survey. The eight items on the subscale record emotional and informational social support. The response categories have a five-level scale.	3 month
Secondary	FAD	The Family Assessment Device (FAD)is based on the McMaster Model of Family Functioning (MMFF), a clinically oriented conceptualization of families. It is a screening instrument only consisting of 53-items. The model identifies six dimensions of family functioning. Scores range from 1 to 4 with 1 reflecting healthy functioning and 4 reflecting unhealthy functioning. The FAD is made up of seven scales.	baseline & 9 month
Secondary	EQ-5D-5L	The EuroQoL Group (EQ)-5D is a generic measurement instrument that uses a standardized, preference-based procedure to describe and investigate health-related quality of life.The EQ-5D-5L is composed of the EQ-5D-5L descriptive system and the EQ Visual Analogue scale (EQ VAS). The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Each level corresponds to 1-digit number expressing the level selected for that dimension.	baseline, 3 & 9 month
Secondary	KIDSCREEN-10:	The KIDSCREEN questionnaire for children is used to record health-related quality of life (HRQoL). The scale ranges from 5 to 50, with a higher score indicating a better quality of life.	baseline & 9 month